Today: 7 February 2026
Subscribe
Browse Category

NASDAQ:VICR News 22 October 2025 - 2 January 2026

Why Vicor (VICR) stock is up today: chip rally, court calendar and earnings date in focus

Why Vicor (VICR) stock is up today: chip rally, court calendar and earnings date in focus

NEW YORK, January 2, 2026, 13:41 ET — Regular session Vicor Corp shares rose 7.5% to $117.85 in early afternoon trading on Friday, in a sharp move for the Nasdaq-listed power-module maker. Trading was light, with about 33,231 shares changing hands by mid-day, MarketBeat data showed. MarketBeat The move puts Vicor back on traders’ screens at the start of 2026, when thin post-holiday liquidity can exaggerate swings in smaller chip-related names. The broader backdrop was supportive for semiconductors even as U.S. stocks were largely muted. The Philadelphia SE Semiconductor index was up 3.4%, Reuters reported, as investors sized up the
2 January 2026
·
Vicor (VICR) Stock Today: Roth Starts Coverage With a $115 Target as AI Data Center Power Thesis Gains Steam (Dec. 17, 2025)

Vicor (VICR) Stock Today: Roth Starts Coverage With a $115 Target as AI Data Center Power Thesis Gains Steam (Dec. 17, 2025)

Vicor Corporation (NASDAQ: VICR) is back in the spotlight on Wednesday, December 17, 2025, after a notable gap-up open and fresh Wall Street commentary that leans into the company’s positioning in next‑generation AI compute power delivery—a theme that has become increasingly market-moving for semiconductor and infrastructure-adjacent names. MarketBeat At the same time, new insider filings have hit the tape—information investors often track closely when a stock has already posted a major run—adding another layer to today’s Vicor narrative. TradingView+1 VICR stock price action on Dec. 17, 2025 Vicor shares opened higher today after closing at $93.45 yesterday, matching reports that
17 December 2025
·
Vicor Stock Skyrockets to 52-Week High After Blockbuster Q3 and AI Licensing Boom

Vicor Stock Skyrockets to 52-Week High After Blockbuster Q3 and AI Licensing Boom

Vicor Corporation (NASDAQ: VICR) shares surged after its Oct. 21 Q3 report, reaching ~$67.82 intraday on Oct. 21 (vs ~$58 the prior close) Marketbeat. The stock is up roughly 30–35% year-to-date (fell to ~$38 low in 2024) and opened Oct 22 near $65–66. Q3 revenue was $110.4 M (up 18.5% YOY) and EPS $0.63, crushing analyst expectations Investing Marketbeat. Analyst firms (Craig-Hallum, Needham) upgraded VICR to Buy with ~$90 price targets, citing strong growth in high-margin IP licensing and next-gen power products Gurufocus Intellectia. Investors are excited by Vicor’s role in AI and data-center power (48V and 800V systems), its recently announced ~$300 M licensing
22 October 2025
··

Stock Market Today

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
Home Depot shares rose 0.7% to $385.15 Friday, trading between $379.10 and $386.37. Investors await a delayed U.S. jobs report Wednesday and CPI data Friday, both postponed by a brief government shutdown. Home Depot reports fourth-quarter earnings Feb. 24. The Dow closed above 50,000 for the first time.
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Go toTop